Lisata Therapeutics President and COO Joshua Lehrer-Graiwer files initial beneficial ownership statement
LSTA•Joshua Lehrer-Graiwer filed a Form 3 reporting 21,548 Lisata Therapeutics shares held directly and 6,260 held indirectly.
1. Ownership filing
Lisata Therapeutics President and COO Joshua Lehrer-Graiwer filed an initial beneficial ownership statement, reporting 21,548 shares held directly and 6,260 shares held indirectly.
